Electromed, Inc.(ELMD)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Electromed, Inc. (ELMD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores ELMD at 60.5/100 on a 32-signal composite quality model, placing it at rank #852 of 2,962 stocks — the top half of the AI-ranked universe. ELMD scores in the top quartile across balance sheet strength (96.2), profitability (77.9). Areas of concern include revenue scale (12.1), which score below median versus the broader universe. Shareholder dilution risk is elevated at 29.2/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Electromed, Inc. reports quarterly revenue of $19.4M, net income of $3.4M, an operating margin of 19.7%. Top institutional holders of ELMD by reported 13-F value include J.E. Simmons & , P.C., BlackRock, VANGUARD CAPITAL MANAGEMENT, based on the most recent SEC filings. ELMD trades on the NYSE exchange and files with the SEC under CIK 1488917. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate ELMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Electromed, Inc. directly from SEC EDGAR.